- Home
- JOB vs CLSD Comparison
JOB vs CLSD Comparison
Compare JOB & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- CLSD
- Stock Information
- Founded
- JOB 1893
- CLSD 2011
- Country
- JOB United States
- CLSD United States
- Employees
- JOB N/A
- CLSD N/A
- Industry
- JOB Diversified Commercial Services
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- CLSD Health Care
- Exchange
- JOB Nasdaq
- CLSD Nasdaq
- Market Cap
- JOB 22.5M
- CLSD 20.4M
- IPO Year
- JOB N/A
- CLSD 2016
- Fundamental
- Price
- JOB $0.20
- CLSD $3.68
- Analyst Decision
- JOB
- CLSD Hold
- Analyst Count
- JOB 0
- CLSD 4
- Target Price
- JOB N/A
- CLSD $65.00
- AVG Volume (30 Days)
- JOB 223.8K
- CLSD 29.9K
- Earning Date
- JOB 12-18-2025
- CLSD 11-07-2025
- Dividend Yield
- JOB N/A
- CLSD N/A
- EPS Growth
- JOB N/A
- CLSD N/A
- EPS
- JOB N/A
- CLSD N/A
- Revenue
- JOB $108,752,000.00
- CLSD $4,166,000.00
- Revenue This Year
- JOB $43.94
- CLSD $98.20
- Revenue Next Year
- JOB N/A
- CLSD $213.77
- P/E Ratio
- JOB N/A
- CLSD N/A
- Revenue Growth
- JOB N/A
- CLSD N/A
- 52 Week Low
- JOB $0.17
- CLSD $3.32
- 52 Week High
- JOB $0.51
- CLSD $17.40
- Technical
- Relative Strength Index (RSI)
- JOB 45.34
- CLSD 54.08
- Support Level
- JOB $0.19
- CLSD $3.68
- Resistance Level
- JOB $0.21
- CLSD $4.08
- Average True Range (ATR)
- JOB 0.01
- CLSD 0.25
- MACD
- JOB -0.00
- CLSD -0.12
- Stochastic Oscillator
- JOB 53.82
- CLSD 18.57
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.